Literature DB >> 26041952

Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

Chantal Bémeur1, Roger F Butterworth2.   

Abstract

Malnutrition is a common feature of chronic liver diseases that is often associated with a poor prognosis including worsening of clinical outcome, neuropsychiatric complications as well as outcome following liver transplantation. Nutritional assessment in patients with cirrhosis is challenging owing to confounding factors related to liver failure. The objectives of nutritional intervention in cirrhotic patients are the support of liver regeneration, the prevention or correction of specific nutritional deficiencies and the prevention and/or treatment of the complications of liver disease per se and of liver transplantation. Nutritional recommendations target the optimal supply of adequate substrates related to requirements linked to energy, protein, carbohydrates, lipids, vitamins and minerals. Some issues relating to malnutrition in chronic liver disease remain to be addressed including the development of an appropriate well-validated nutritional assessment tool, the identification of mechanistic targets or therapy for sarcopenia, the development of nutritional recommendations for obese cirrhotic patients and liver-transplant recipients and the elucidation of the roles of vitamin A hepatotoxicity, as well as the impact of deficiencies in riboflavin and zinc on clinical outcomes. Early identification and treatment of malnutrition in chronic liver disease has the potential to lead to better disease outcome as well as prevention of the complications of chronic liver disease and improved transplant outcomes.

Entities:  

Keywords:  AAAs, aromatic amino acids; BCAAs, branched-chain amino acids; BMI, body mass index; CNS, central nervous system; CONUT, controlling nutritional status; HE, hepatic encephalopathy; ISHEN, International Society for Hepatic Encephalopathy and Nitrogen metabolism; NAFLD, non-alcoholic fatty liver disease; NASH, non-alcoholic steato-hepatitis; PNI, prognostic nutritional index; complications; hepatic encephalopathy; liver disease; liver transplantation; nutritional status

Year:  2015        PMID: 26041952      PMCID: PMC4442848          DOI: 10.1016/j.jceh.2015.02.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  129 in total

1.  [Vitamin B12 concentration in the blood of alcoholics].

Authors:  Bogdan Cylwik; Małgorzata Czygier; Marta Daniluk; Lech Chrostek; Maciej Szmitkowski
Journal:  Pol Merkur Lekarski       Date:  2010-02

Review 2.  Selenium, selenoproteins and human health: a review.

Authors:  K M Brown; J R Arthur
Journal:  Public Health Nutr       Date:  2001-04       Impact factor: 4.022

3.  Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.

Authors:  Sandhya Narasimhan; Kuppan Gokulakrishnan; Rangasamy Sampathkumar; Syed Farooq; Radhakrishnan Ravikumar; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Clin Biochem       Date:  2010-04-14       Impact factor: 3.281

4.  Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology.

Authors:  Mikkel Malham; Søren Peter Jørgensen; Peter Ott; Jørgen Agnholt; Hendrik Vilstrup; Mette Borre; Jens F Dahlerup
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

5.  ESPEN Guidelines on Enteral Nutrition: Liver disease.

Authors:  M Plauth; E Cabré; O Riggio; M Assis-Camilo; M Pirlich; J Kondrup; P Ferenci; E Holm; S Vom Dahl; M J Müller; W Nolte
Journal:  Clin Nutr       Date:  2006-05-16       Impact factor: 7.324

6.  Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction.

Authors:  C Rose; R F Butterworth; J Zayed; L Normandin; K Todd; A Michalak; L Spahr; P M Huet; G Pomier-Layrargues
Journal:  Gastroenterology       Date:  1999-09       Impact factor: 22.682

7.  Neurologic complications of liver transplantation.

Authors:  D P Vogt; R J Lederman; W D Carey; T A Broughan
Journal:  Transplantation       Date:  1988-06       Impact factor: 4.939

Review 8.  Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

Authors:  Farida Millwala; Geoffrey C Nguyen; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

9.  Manganese and chronic hepatic encephalopathy.

Authors:  D Krieger; S Krieger; O Jansen; P Gass; L Theilmann; H Lichtnecker
Journal:  Lancet       Date:  1995-07-29       Impact factor: 79.321

10.  Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure.

Authors:  Chantal Bémeur; Paul Desjardins; Roger F Butterworth
Journal:  J Nutr Metab       Date:  2010-12-22
View more
  4 in total

1.  Hepatobiliary Quiz (Answers)-15 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-10-27

Review 2.  Current Medical Treatment for Alcohol-Associated Liver Disease.

Authors:  Gustavo Ayares; Francisco Idalsoaga; Luis A Díaz; Jorge Arnold; Juan P Arab
Journal:  J Clin Exp Hepatol       Date:  2022-02-12

Review 3.  The Analysis of Food Intake in Patients with Cirrhosis Waiting for Liver Transplantation: A Neglected Step in the Nutritional Assessment.

Authors:  Francesco Palmese; Ilaria Bolondi; Ferdinando Antonino Giannone; Giacomo Zaccherini; Manuel Tufoni; Maurizio Baldassarre; Paolo Caraceni
Journal:  Nutrients       Date:  2019-10-15       Impact factor: 5.717

Review 4.  Molecular Mechanism Contributing to Malnutrition and Sarcopenia in Patients with Liver Cirrhosis.

Authors:  Fatuma Meyer; Karen Bannert; Mats Wiese; Susanne Esau; Lea F Sautter; Luise Ehlers; Ali A Aghdassi; Cornelia C Metges; Leif-A Garbe; Robert Jaster; Markus M Lerch; Georg Lamprecht; Luzia Valentini
Journal:  Int J Mol Sci       Date:  2020-07-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.